TScan Therapeutics (TCRX) Asset Utilization Ratio (2021 - 2025)
TScan Therapeutics (TCRX) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.04 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio rose 437.01% to 0.04 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.04, a 437.01% increase, with the full-year FY2025 number at 0.03, up 293.16% from a year prior.
- Asset Utilization Ratio was 0.04 for Q4 2025 at TScan Therapeutics, up from 0.03 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q1 2023 to a low of 0.01 in Q4 2024.
- A 5-year average of 0.05 and a median of 0.05 in 2021 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: crashed 88.99% in 2024, then soared 437.01% in 2025.
- TScan Therapeutics' Asset Utilization Ratio stood at 0.05 in 2021, then soared by 43.88% to 0.07 in 2022, then dropped by 4.19% to 0.07 in 2023, then plummeted by 88.99% to 0.01 in 2024, then surged by 437.01% to 0.04 in 2025.
- Per Business Quant, the three most recent readings for TCRX's Asset Utilization Ratio are 0.04 (Q4 2025), 0.03 (Q3 2025), and 0.02 (Q2 2025).